Test type | MRI | CT | PET | 18F-NaF or bone scan | Biopsy | Other | Total |
Tests planned before 68Ga-PSMA PET (Q1) | 56 (13%) | 77 (17%) | 145 (33%) | 144 (33%) | 8 (2%) | 13 (3%) | 443 |
Tests prevented by 68Ga-PSMA PET (Q2) | 16 (11%) | 43 (29%) | 17 (11%) | 52 (35%) | 18 (12%) | 4 (3%) | 150 |
Tests triggered after 68Ga-PSMA PET (Q2) | 8 (11%) | 7 (10%) | 2 (3%) | 5 (7%) | 44 (60%) | 7 (10%) | 73 |